ATE227712T1 - Flavone-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammenstellungen - Google Patents

Flavone-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammenstellungen

Info

Publication number: ATE227712T1
Authority: AT; Austria
Prior art keywords: alkyl; optionally substituted; alkoxy; optionally; aryl
Prior art date: 1996-09-27

Application number

AT97402202T

Other languages

English (en)

Inventor

Alain Dhainaut

Guy Lewin

Emmanuel Canet

Michel Lonchampt

Yves Rolland

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-09-27

Filing date

1997-09-23

Publication date

2002-11-15

1997-09-23 Application filed by Servier Lab filed Critical Servier Lab

2002-11-15 Application granted granted Critical

2002-11-15 Publication of ATE227712T1 publication Critical patent/ATE227712T1/de

Links

229930003944 flavone Natural products 0.000 title 1
150000002213 flavones Chemical class 0.000 title 1
235000011949 flavones Nutrition 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 6
125000003545 alkoxy group Chemical group 0.000 abstract 4
125000003118 aryl group Chemical group 0.000 abstract 3
125000000753 cycloalkyl group Chemical group 0.000 abstract 3
125000001072 heteroaryl group Chemical group 0.000 abstract 3
239000004215 Carbon black (E152) Substances 0.000 abstract 2
229910052736 halogen Inorganic materials 0.000 abstract 2
150000002367 halogens Chemical group 0.000 abstract 2
229930195733 hydrocarbon Natural products 0.000 abstract 2
125000000547 substituted alkyl group Chemical group 0.000 abstract 2
MUQNGPZZQDCDFT-JNQJZLCISA-N Halcinonide Chemical group C1CC2=CC(=O)CC[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@@H]2O MUQNGPZZQDCDFT-JNQJZLCISA-N 0.000 abstract 1
125000002947 alkylene group Chemical group 0.000 abstract 1
150000002212 flavone derivatives Chemical class 0.000 abstract 1
125000002541 furyl group Chemical group 0.000 abstract 1
229940028332 halog Drugs 0.000 abstract 1
150000002430 hydrocarbons Chemical class 0.000 abstract 1
125000002883 imidazolyl group Chemical group 0.000 abstract 1
125000001041 indolyl group Chemical group 0.000 abstract 1
125000005956 isoquinolyl group Chemical group 0.000 abstract 1
125000001786 isothiazolyl group Chemical group 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
125000001624 naphthyl group Chemical group 0.000 abstract 1
230000003287 optical effect Effects 0.000 abstract 1
125000002971 oxazolyl group Chemical group 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
-1 polycyclic hydrocarbon Chemical class 0.000 abstract 1
125000003373 pyrazinyl group Chemical group 0.000 abstract 1
125000003226 pyrazolyl group Chemical group 0.000 abstract 1
125000002098 pyridazinyl group Chemical group 0.000 abstract 1
125000004076 pyridyl group Chemical group 0.000 abstract 1
125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
125000000168 pyrrolyl group Chemical group 0.000 abstract 1
125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 abstract 1
125000005493 quinolyl group Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000000335 thiazolyl group Chemical group 0.000 abstract 1
125000001544 thienyl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrane Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT97402202T 1996-09-27 1997-09-23 Flavone-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammenstellungen ATE227712T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9611808A FR2753969B1 (fr)	1996-09-27	1996-09-27	Nouveaux derives de flavones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number	Publication Date
ATE227712T1 true ATE227712T1 (de)	2002-11-15

Family

ID=9496129

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97402202T ATE227712T1 (de)	1996-09-27	1997-09-23	Flavone-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammenstellungen

Country Status (18)

Country	Link
US (1)	US5889003A (de)
EP (1)	EP0832886B1 (de)
JP (1)	JPH10114766A (de)
CN (1)	CN1094936C (de)
AT (1)	ATE227712T1 (de)
AU (1)	AU728990B2 (de)
BR (1)	BR9704900A (de)
CA (1)	CA2216617C (de)
DE (1)	DE69717044T2 (de)
DK (1)	DK0832886T3 (de)
ES (1)	ES2187738T3 (de)
FR (1)	FR2753969B1 (de)
HU (1)	HUP9701588A3 (de)
NO (1)	NO974455L (de)
NZ (1)	NZ328858A (de)
PL (1)	PL322297A1 (de)
PT (1)	PT832886E (de)
ZA (1)	ZA978652B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU709191B2 (en) *	1995-09-11	1999-08-26	Osteoarthritis Sciences, Inc.	Protein tyrosine kinase inhibitors for treating osteoarthritis
BR9913152A (pt)	1998-08-26	2001-05-15	Smithkline Beecham Corp	Terapias para tratamento de doenças pulmonares
EP1115718A1 (de) *	1998-09-24	2001-07-18	Mitsubishi Chemical Corporation	Hydroxyflavon derivate als tau protein kinase 1 hemmer
CA2715683A1 (en)	1999-08-21	2001-03-01	Nycomed Gmbh	Synergistic combination
US6806257B1 (en)	1999-10-20	2004-10-19	Board Of Trustees Of Southern Illinois University	Flavones as inducible nitric oxide synthase inhibitors, cyclooxygenase-2 inhibitors and potassium channel activators
US6334998B1 (en) *	1999-12-07	2002-01-01	Parker Hughes Institute	Estrogens for treating ALS
EP1127572A3 (de) *	2000-02-25	2003-05-02	Basf Aktiengesellschaft	Verwendung von Flavonen zur Behandlung von Cyclooxygenase-2 ermittelten Krankheiten
US6472436B1 (en) *	2000-07-17	2002-10-29	The Salk Institute For Biological Studies	Methods for protecting cells from amyloid toxicity and for inhibiting amyloid protein production
DE10104350A1 (de)	2001-02-01	2002-08-14	Merck Patent Gmbh	Verfahren zur Herstellung von Flavon Derivaten
DE10232595A1 (de) *	2002-07-18	2004-02-05	Merck Patent Gmbh	Lichtschutzmittel
US7153824B2 (en)	2003-04-01	2006-12-26	Applied Research Systems Ars Holding N.V.	Inhibitors of phosphodiesterases in infertility
JP5058481B2 (ja) *	2005-11-28	2012-10-24	丸善製薬株式会社	角化細胞増殖剤、サイクリックａｍｐホスホジエステラーゼ阻害剤、及び保湿剤
CA2661850A1 (en) *	2006-09-01	2008-03-06	Kyorin Pharmaceutical Co., Ltd.	Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor containing the same
CN101148444A (zh) *	2006-09-20	2008-03-26	上海特化医药科技有限公司	黄酮衍生物、制备方法及应用
KR100930467B1 (ko) *	2007-06-07	2009-12-08	동아제약주식회사	점액분비를 촉진시키는 3',4',5-트리메톡시 플라본 유도체화합물, 그의 제조방법 및 약학적 용도
JP4559531B1 (ja) *	2009-12-03	2010-10-06	ウシオケミックス株式会社	ノビレチンの製造方法
CN103059005B (zh) *	2012-11-22	2015-04-22	中南民族大学	白杨素酰胺衍生物及其医药用途
CN105906598B (zh) *	2016-05-19	2018-05-08	江苏耐雀生物工程技术有限公司	白杨素衍生物及其制备方法和应用
WO2026068627A1 (en)	2024-09-25	2026-04-02	Institut Gustave Roussy	Flavonoid derivatives compounds, and their use as drugs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2623808B1 (fr) *	1987-12-01	1990-03-09	Adir	Nouveaux derives flavonoides (benzyl-4 piperazinyl-1)-2 oxo-2 ethylene substitues, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2689127B1 (fr) *	1992-03-31	1994-05-06	Adir Cie	Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2748025B1 (fr) *	1996-04-25	1998-10-30	Adir	Nouveaux acides et esters de la diosmetine, et les compositions pharmaceutiques les contenant

1996
- 1996-09-27 FR FR9611808A patent/FR2753969B1/fr not_active Expired - Fee Related
1997
- 1997-09-23 AT AT97402202T patent/ATE227712T1/de not_active IP Right Cessation
- 1997-09-23 ES ES97402202T patent/ES2187738T3/es not_active Expired - Lifetime
- 1997-09-23 EP EP97402202A patent/EP0832886B1/de not_active Expired - Lifetime
- 1997-09-23 DE DE69717044T patent/DE69717044T2/de not_active Expired - Fee Related
- 1997-09-23 PT PT97402202T patent/PT832886E/pt unknown
- 1997-09-23 DK DK97402202T patent/DK0832886T3/da active
- 1997-09-25 PL PL97322297A patent/PL322297A1/xx unknown
- 1997-09-26 JP JP9261323A patent/JPH10114766A/ja active Pending
- 1997-09-26 CA CA002216617A patent/CA2216617C/fr not_active Expired - Fee Related
- 1997-09-26 BR BR9704900A patent/BR9704900A/pt not_active IP Right Cessation
- 1997-09-26 NZ NZ328858A patent/NZ328858A/en unknown
- 1997-09-26 HU HU9701588A patent/HUP9701588A3/hu unknown
- 1997-09-26 CN CN97120535A patent/CN1094936C/zh not_active Expired - Fee Related
- 1997-09-26 AU AU39271/97A patent/AU728990B2/en not_active Ceased
- 1997-09-26 US US08/968,837 patent/US5889003A/en not_active Expired - Fee Related
- 1997-09-26 ZA ZA9708652A patent/ZA978652B/xx unknown
- 1997-09-26 NO NO974455A patent/NO974455L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP0832886A1 (de)	1998-04-01
DE69717044D1 (de)	2002-12-19
FR2753969B1 (fr)	1998-10-30
PL322297A1 (en)	1998-03-30
PT832886E (pt)	2003-03-31
US5889003A (en)	1999-03-30
FR2753969A1 (fr)	1998-04-03
CA2216617C (fr)	2002-12-03
CN1179422A (zh)	1998-04-22
ES2187738T3 (es)	2003-06-16
NZ328858A (en)	1998-01-26
HU9701588D0 (en)	1997-11-28
NO974455L (no)	1998-03-30
CA2216617A1 (fr)	1998-03-27
BR9704900A (pt)	1998-10-27
CN1094936C (zh)	2002-11-27
JPH10114766A (ja)	1998-05-06
AU3927197A (en)	1998-04-02
HUP9701588A2 (hu)	1998-12-28
ZA978652B (en)	1998-03-27
DK0832886T3 (da)	2003-03-10
DE69717044T2 (de)	2003-07-24
EP0832886B1 (de)	2002-11-13
NO974455D0 (no)	1997-09-26
AU728990B2 (en)	2001-01-25
HUP9701588A3 (en)	1999-03-01

Similar Documents

Publication	Publication Date	Title
ATE227712T1 (de)	2002-11-15	Flavone-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammenstellungen
ATE159721T1 (de)	1997-11-15	Verzweigte alkylaminothiazolederivate, verfahren zu ihrer herstellung und pharmazeutische zusammenstellungen die sie enthalten
DE69918404D1 (de)	2004-08-05	Aminophenoxyessigsäure derivate als neuroschützende mittel
ATE254612T1 (de)	2003-12-15	Zuckerderivate, geliermittel, geliermittelzubereitungen, verfahren zu ihrer herstellung und gelzubereitungen
HRP20021023B1 (en)	2006-08-31	Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
PT85014A (fr)	1987-07-01	Derives de benzo ]b" thiophene et benzo ]b" furannecarboxamides leurs procedes de preparation et les medicaments les contenant
FR2713636B1 (fr)	1996-01-05	Nouveaux dérivés naphtaléniques, leur procédé de préparation, et les compositions pharmaceutiques qui les contiennent.
ATE156829T1 (de)	1997-08-15	Substituierte aminophosphonatderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
SE8501421L (sv)	1985-09-24	1-(hydroximetyl)-1,6,7,11b-tetrahydro-2h,4h-(1,3)-oxazino- eller -tiazino(4,3-a)isokinolinderivat, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dem
DE3670081D1 (de)	1990-05-10	Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen.
ATE202564T1 (de)	2001-07-15	Aminomethylheterozyclischederivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
AR029468A1 (es)	2003-07-02	Derivados de aminoacidos n-mercaptoacilados, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
ES2172294T3 (es)	2002-09-16	Nuevos derivados del 1-indanol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE3773597D1 (de)	1991-11-14	1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE222253T1 (de)	2002-08-15	Camptothecin analoge verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ATE28871T1 (de)	1987-08-15	Disubstituierte piperidine,verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE59507361D1 (de)	2000-01-13	Cyclohexan-Derivate, Verfahren zu ihrer Herstellung und die Verwendung als Glukose-6-Phosphatase Inhibitoren
PT83786A (de)	1986-12-01	Neue basisch substituierte pyridinverbindungen verfahren zu ihrer herstellung die sie enthaltenden arzneimittel und ihre verwendung
DE59712053D1 (de)	2004-12-09	4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE59606328D1 (de)	2001-02-22	Verfahren zur Herstellung von gegebenenfalls 2-substituierten 5-Chlor-imidazol-4-carbaldehyden
PT93904A (pt)	1990-11-20	Processo para a preparacao de novos derivados benzotiazolinonicos e de composicoes farmaceuticas que os contem
DE59712054D1 (de)	2004-12-09	4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE3667976D1 (de)	1990-02-08	3-iminopyridazinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE69706206D1 (de)	2001-09-27	Von Neurokininen abgeleitete Pseudopeptide, Verfahren für ihre Herstellung und sie enthaltende pharmazeutische Zubereitungen
ES454285A1 (es)	1977-11-16	Procedimiento para preparar derivados de 4-amina trans-deca-hidroquinolina.

Legal Events

Date

Code

Title

Description

2003-05-15

UEP

Publication of translation of european patent specification

Ref document number: 0832886

Country of ref document: EP

2005-06-15

REN

Ceased due to non-payment of the annual fee